Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis

Clinical and Experimental Metastasis

Volumn 23, Issue 3-4, 2006, Pages 209-222

  Zhang, Xin ^a,b   Su, Ling ^a   Pirani, Ali A ^a   Wu, Haiyan ^c   Zhang, Hongzheng ^a   Shin, Dong M ^a   Gernert, Kim M ^a   Chen, Zhuo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c EMORY UNIVERSITY   (United States)

Author keywords

Anoikis; Cell cycle; DNA microarray; EMT; Metastasis; SCCHN

Indexed keywords

ARTICLE; CANCER SURVIVAL; CARCINOMA CELL; CELL ADHESION; CONTROLLED STUDY; DNA MICROARRAY; GENOTYPE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CYCLIN E; DISEASE MODELS, ANIMAL; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE;

EID: 33750550491     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-006-9031-0     Document Type: Article

References (56)

1. Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA Cancer J Clin 49:33-64
2. Jemal A, Murray T, Ward E et al (2005) Cancer statistics, 2005. CA Cancer J Clin 55:10-30
3. Som PM (1992) Detection of metastasis in cervical lymph nodes: CT and MRI criteria and differential diagnosis. Am J Radiol 158:961-969
4. Cancer Facts & Figures 2005 (2005) Edit: American Cancer Society, p 17
5. Johnson JT, Barnes EL, Myers EN et al (1981) The extracapsular spread of tumors in cervical node metastasis. Arch Otolaryngol 107:725-729
6. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572
7. Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Caner 3:1-6
8. Fidler IJ (2002) The organ microenvironment and cancer metastasis. Differentiation 70:498-505
9. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746
10. Thompson EW, Newgreen DF, Tarin D (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65:5991-5995; discussion 5995
11. Tarin D, Thompson EW, Newgreen DF (2005) The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 65:5996-6000; discussion 6000-6001
12. Frisch SM, Francis H (1994) Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124:619-626
13. Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13:555-562
14. Grossmann J (2002) Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 7:247-260
15. Zhang X, Liu Y, Gilcrease MZ et al (2002) A lymph node metastatic mouse model reveals alteration of metastasis-related gene expression in metastatic human oral cancer sublines selected from a poorly metastatic parental cell line. Cancer 95:1663-1672
16. Chen Z, Zhang K, Zhang X et al (2003) Comparison of gene expression between metastatic derivatives and their poorly metastatic parental cells implicates curial tumor-environment interaction in metastasis of head and neck squamous cell carcinoma. Clin Exp Met 20:335-342
17. Fiucci G, Ravid D, Reich R, Liscovitch M (2002) Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21:2365-2375
18. Fidler IJ, Kripke ML (1977) Metastasis results from preexisting variant cells within a malignant tumor. Science 197(4306):893-895
19. Heppner G, Yamashina K, Miller B, Miller F (1986) Tumor heterogeneity in metastasis. Prog Clin Biol Res 212:45-59
20. Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49-54
21. Fidler IJ, Kripke ML (2003) Genomic analysis of primary tumors does not address the prevalence of metastatic cells in the population. Nat Genet 34:23; author reply 25
22. Zhang X, Hunt JL, Landsittel DP et al (2004) Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res 10:8451-8459
23. Wang J, Xi L, Hunt JL et al (2004) Expression pattern of chemokine receptors 6 (CCR6) and 7 (CCR7) in squamous cell carcinoma of the head and neck identifies a novel metastatic phenotype. Cancer Res 64:1861-1866
24. Chen Z, Sun W, Zhang X, Choe M, Shin DM (2005) Selection of metastasis-related genes from a lymph node metastasis mouse model of the head and neck cancer. Clin Exp Met 21:638
25. Jones J, Out H, Spentzos D et al (2005) Gene signature of progression and metastasis in renal cell cancer. Clin Cancer Res 11:5730-5739
26. Xi L, Lyons-Weiler J, Coello MC et al (2005) Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas. Clin Cancer Res 11:4128-4235
27. Weiget B, Glas AM, Wessels LFA, Witteveen AT, Peterse JL (2003) Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci USA 100:15901-15905
28. Paris PL, Weinberg V, Simko J (2005) Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers 20:141-145
29. Roepman P, Wessels LFA, Kettelarij N et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182-186
30. Chung CH, Parker JS, Karaca G et al (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5:489-500
31. Eckhardt BL, Parker BS, van Laar RK et al (2005) Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Mol Cancer Res 3:1-13
32. Kluger HM, Chelouche Lev D, Kluger Y et al (2005) Using a xenograft model of human breast cancer metastasis to find gene associated with clinically aggressive disease. Cancer Res 65:5578-5587
33. Huber MA, Kraut N, Beug H (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17:548-558
34. Thiery JP (2002) Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2:442-454
35. Bankfalvi A, KraBort M, Buchwalow LB, Vegh A, Feiszeghy E, Piffiko J (2002) Gains and losses of adhesion molecules (CD44, E-cadherin, and β-catenin) during oral carcinogenesis and tumor progression. J Pathol 198:343-351
36. Bankfalvi A, Krassort M, Vegh A, Felszeghy E, Piffko L (2002) Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med 31:450-457
37. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A (2002) The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 109:987-991
38. Zavadil J, Bottinger EP (2005) TGF-β and epithelial-to- mesenchychymal transitions. Oncogene 24:5764-5774
39. Bachman KE, Park BH (2005) Duel nature of TGF-β signaling: tumor suppressor vs. tumor promoter. Curr Opin Oncol 17:49-54
40. Summy JM, Gallick GE (2003) Src family kinase in tumor progression and metastasis. Cancer Met Rev 22:337-358
41. Avizienyte E, Brunton VG, Fincham VJ, Frame MC (2005) The SRC-induced mesenchymal state in late-stage colon cancer cells. Cell Tissues Organs 179:73-80
42. Playford MP, Schaller MD (2004) The interplay between Src and integrins in normal and tumor biology. Oncogene 23:7928-7946
43. Ishizawar R, Parsons SJ (2004) C-Src and cooperating partners in human cancer. Cancer Cell 6:209-214
44. Engelberg D (2004) Stress-activated protein kinases-tumor suppressors or tumor initiators? Semi Cancer Biol 14:271-282
45. Bhowmick NA, Zent R, Ghiass M, McDonnell M, Moses H (2001) Integrin β1 signaling is necessary for transforming growth factor-β activation of p38MAPK and epithelial plasticity. J Biol Chem 276:46707-46713
46. Shin I, Kim S, Song H, Kim H-RC, Moon A (2005) H-Ras-specific activation of Rac-MKK3/6-p38 Pathway. J Biol Chem 280:14675-14683
47. Laferriere J, Houle F, Huot J (2002) Regulation of the metastatic process by E-selectin and stress-activated protein kinase-2/p38. Ann NY Acad Sci 973:562-572
48. Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL (2005) Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer 4:21
49. Okamoto T, Schlegel A, Scherer PE, Lisanti MP (1998) Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J Biol Chem 273:5419-5422
50. Liu P, Rudick M, Anderson RG (2002) Multiple functions of caveolin-1. J Biol Chem 277:41295-41298
51. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563-572
52. Luzzi KJ, MacDonald IC, Schmidt EE et al (1998) Dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865-873
53. Wong CW, Lee A, Shientag L et al (2001) Apoptosis: an early event in metastatic inefficiency. Cancer Res 61:333-338
54. Kramer RH, Shen X, Zhou H (2005) Tumor cell invasion and survival in head and neck cancer. Cancer Met Rev 24:35-45
55. Yoon Y, Liang Z, Kang S (2005) CXCR4 antagonist blocks both primary tumor and metastasis in head and neck cancer animal models. Proceedings: AACR 46:Abstract 2327
56. Moroy T, Geisen C (2004) Cyclin E. Int J Biochem Cell Biol 36:1424-1439